These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15887952)

  • 1. Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases.
    Zhao L; Brinton RD
    J Med Chem; 2005 May; 48(10):3463-6. PubMed ID: 15887952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of estrogen receptor-beta selective ligands.
    Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
    J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J; Li W; Zhao Y; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2008 Mar; 112(9):2719-26. PubMed ID: 18266357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target specific virtual screening: optimization of an estrogen receptor screening platform.
    Knox AJ; Meegan MJ; Sobolev V; Frost D; Zisterer DM; Williams DC; Lloyd DG
    J Med Chem; 2007 Nov; 50(22):5301-10. PubMed ID: 17918820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J; Li W; Liu G; Tang Y; Jiang H
    J Phys Chem B; 2009 Jul; 113(30):10436-44. PubMed ID: 19583238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
    J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
    Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
    J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
    Wolohan P; Reichert DE
    J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
    De Angelis M; Stossi F; Waibel M; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2005 Dec; 13(23):6529-42. PubMed ID: 16099659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based quantitative structure--activity relationship modeling of estrogen receptor β-ligands.
    Dong X; Hilliard SG; Zheng W
    Future Med Chem; 2011 Jun; 3(8):933-45. PubMed ID: 21707397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
    Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
    J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
    Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
    Wilkening RR; Ratcliffe RW; Tynebor EC; Wildonger KJ; Fried AK; Hammond ML; Mosley RT; Fitzgerald PM; Sharma N; McKeever BM; Nilsson S; Carlquist M; Thorsell A; Locco L; Katz R; Frisch K; Birzin ET; Wilkinson HA; Mitra S; Cai S; Hayes EC; Schaeffer JM; Rohrer SP
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3489-94. PubMed ID: 16632357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.
    Norman BH; Richardson TI; Dodge JA; Pfeifer LA; Durst GL; Wang Y; Durbin JD; Krishnan V; Dinn SR; Liu S; Reilly JE; Ryter KT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5082-5. PubMed ID: 17662603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.